A Randomized Phase 2 Trial of ALIMTA [pemetrexed] Plus a Comparator Versus Leucovorin [folinic acid] Modulated Fluorouracil Plus a Comparator in First Line Treatment of Locally Advanced or Metastatic Colorectal Cancer

Trial Profile

A Randomized Phase 2 Trial of ALIMTA [pemetrexed] Plus a Comparator Versus Leucovorin [folinic acid] Modulated Fluorouracil Plus a Comparator in First Line Treatment of Locally Advanced or Metastatic Colorectal Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 21 May 2008

At a glance

  • Drugs Fluorouracil; Folinic acid; Irinotecan; Pemetrexed
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 May 2008 Results have been published (1110409)
    • 28 Aug 2006 Status change
    • 28 Aug 2006 The expected completion date for this trial is now .
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top